Capri Global Capital Ltd. sees a credit rating action

The company’s regulatory disclosure states that CareEdge Global IFSC Limited assigned a `CareEdge BB-/Positive` rating to Capri Global Capital’s proposed USD 300 million senior secured notes on 1 September 2026. ^[1] The same `BB-/Positive` rating was also assigned to the USD 1 billion GMTN programme and the issuer rating. ^[1]

Alignment with domestic ratings: the notes’ rating is directly aligned with CareEdge Global’s own issuer rating—same `BB-` grade and Positive outlook. However, a CRISIL or ICRA long-term issuer rating is not identified in the cited disclosures, so no like-for-like comparison with those agencies can be made.

The `ICRA A1+` rating reported for Capri Global relates to commercial paper, which is a short-term instrument and is therefore not directly comparable with the long-term foreign-currency senior secured notes. ^[2]

There is also separate news coverage of a Fitch `BB-(EXP)` expected rating for the proposed bonds, but this is an expected Fitch rating rather than the final CareEdge rating reported in the company’s regulatory filing. ^[3]

CGCL’s latest reported domestic cost of borrowing is 9.1% for Q1 FY27, down from 9.7% a year earlier. This is the relevant WACB benchmark for comparison. ^[4]

The proposed USD 300 million notes were marketed at approximately a 7.75% coupon for a 3-year-and-3-month maturity. ^[5] On a nominal, unhedged basis, that is 135 bps below the 9.1% domestic borrowing cost:

• Domestic WACB: 9.10%
• Dollar-note coupon: 7.75%
• Nominal difference: 1.35 percentage points lower

However, the correct comparison is:

All-in INR borrowing cost = 7.75% dollar coupon + currency-hedging cost + issuance-related costs

The reported material does not quantify CGCL’s hedge premium or the amortised issuance expenses, so the precise all-in cost cannot be established. The break-even hedge cost is 1.35 percentage points:

• If hedging and other annualised costs are below 1.35%, the foreign borrowing would remain cheaper than the current domestic WACB.
• If they are above 1.35%, the offshore borrowing would be more expensive in INR terms.
• At exactly 1.35%, the two funding options would be approximately cost-neutral.

This matters because CGCL’s existing funding remains predominantly domestic—reported at roughly 80% bank/domestic funding, with capital-market borrowings targeted to rise from approximately 20% toward 40-50% of total debt. ^[6] The offshore issue therefore provides funding diversification and potentially longer-tenor capital, but it should not be treated as a funding-cost saving until the hedge rate and all-in rupee cost are disclosed.

The disclosed materials do not provide a pro forma CAR or gearing estimate. The USD 300 million instrument is a proposed senior secured debt issue, not an equity raise, under CGCL’s USD 1 billion GMTN programme ^[1]. Therefore, it should not be treated as an immediate capital-equity infusion.

• CAR: The latest cited pre-issuance reference is 24.7% for both entities ^[7]. The notes would not automatically increase CAR unless they qualify as regulatory capital, which has not been stated. If the proceeds are deployed into additional lending and risk-weighted assets grow, CAR would generally be diluted; if retained as cash or used to refinance existing borrowings, the immediate effect could be limited. A numerical post-issuance CAR has not been reported.
• Gearing: The latest cited leverage reference is 3.7x ^[7]. Since the proposed notes add debt without adding equity, gearing should rise mechanically unless the proceeds are used to repay existing debt or equity/net worth increases before measurement. The post-issuance ratio cannot be calculated reliably without the issue-date exchange rate, the amount actually issued, debt repayment details, and the company’s precise gearing definition and denominator.
• Maximum leverage policy: No stated post-issuance maximum permissible leverage or gearing ceiling appears in the cited disclosures. The announcement confirms the issue size, instrument and programme but does not set a leverage cap ^[1].

Analytical implication: The raise improves funding access and liquidity optionality, but its balance-sheet effect is debt-led rather than capital-led. The key missing disclosures are use of proceeds, regulatory-capital treatment of the notes, and management’s pro forma CAR/gearing targets.